丹麦老年人停用他汀与心血管事件的关系
该队列研究纳入丹麦所有截至2011年1月1日已连续服用他汀至少5年、年龄75岁及以上者,随访至2016年12月31日。按一级预防(无心血管病史,27463人)和二级预防(有心血管病史,39955人)分别分析,采用逆概率治疗加权校正混杂。两个队列中停用他汀者的MACE发生率均高于继续服用者:一级预防加权率差9/1000人年(95%CI 5-12),校正亚风险比1.32(95%CI 1.18-1.48),相当于每112名停药者每年多1例MACE;二级预防加权率差13/1000人年(95%CI 8-17),校正亚风险比1.28(95%CI 1.18-1.39),相当于每77名停药者每年多1例MACE。作者认为需要随机临床试验提供有力证据。
要点
- 一级预防队列(无心血管病史,n=27463):停用他汀者MACE加权率差9/1000人年(95%CI 5-12),校正亚风险比1.32(95%CI 1.18-1.48)。
- 二级预防队列(有心血管病史,n=39955):停用他汀者MACE加权率差13/1000人年(95%CI 8-17),校正亚风险比1.28(95%CI 1.18-1.39)。
- 一级预防中每112名停用他汀者每年多1例MACE;二级预防中每77名停用他汀者每年多1例MACE。
- 两个队列中停用他汀均与MACE发生率更高相关,作者据此认为需要随机临床试验提供有力证据。
适用人群与场景
- 丹麦所有截至2011年1月1日已连续服用他汀至少5年、年龄75岁及以上者,随访至2016年12月31日。
- 分析分一级预防(无心血管病史,n=27463;中位年龄79岁[IQR 77-83岁],女性18134人[66%])和二级预防(有心血管病史,n=39955;中位年龄80岁[IQR 77-84岁],女性18717人[47%])。
研究设计与关键结果
- 研究类型为队列研究,纳入67418名长期他汀使用者,采用逆概率治疗加权校正混杂,按一级预防和二级预防分别分析。
- 一级预防队列:停用他汀者MACE加权率差9/1000人年(95%CI 5-12),校正亚风险比1.32(95%CI 1.18-1.48),相当于每112名停药者每年多1例MACE。
- 二级预防队列:停用他汀者MACE加权率差13/1000人年(95%CI 8-17),校正亚风险比1.28(95%CI 1.18-1.39),相当于每77名停药者每年多1例MACE。
- MACE包括心肌梗死、缺血性卒中或短暂性脑缺血发作、冠状动脉血运重建、以及死于心肌梗死或缺血性卒中。
证据类型、等级与局限
- 证据类型:队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在75岁及以上长期服用他汀者中,停用他汀与MACE发生率更高相关;作者认为需要随机临床试验提供有力证据。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Statin use is common in older persons. Given uncertainties in ongoing benefit, changes in health status, and shifting goals of care and preferences, statin discontinuation may be considered in some older persons, although there is currently little evidence to guide this decision.
OBJECTIVE: To evaluate the association between statin discontinuation and the rate of major adverse cardiovascular events (MACE) among people aged 75 years or older who receive long-term statin treatment.
DESIGN, SETTING, AND PARTICIPANTS: This cohort study included all persons in Denmark aged 75 years or older who were treated with statins for at least 5 consecutive years as of January 1, 2011. Participants were followed up until December 31, 2016. Data were analyzed from July to November, 2020.
EXPOSURE: Statin discontinuation.
MAIN OUTCOMES AND MEASURES: Rate of occurrence of MACE and its components (myocardial infarction, ischemic stroke or transient ischemic attack, coronary revascularization, and death due to myocardial infarction or ischemic stroke) in persons continuing statins compared with those discontinuing statins. Confounding adjustment was done using inverse probability of treatment weighting. Analyses were conducted separately for primary prevention (no history of cardiovascular disease) and secondary prevention (history of cardiovascular disease).
RESULTS: The study included 67 418 long-term statin users, including 27 463 in the primary prevention analysis (median age, 79 years [IQR, 77-83 years]; 18 134 [66%] female) and 39 955 in the secondary prevention analysis (median age, 80 years [IQR, 77-84 years]; 18 717 [47%] female). In both primary and secondary prevention analyses, the rate of MACE was higher among persons who discontinued statins compared with those who continued statins. In the primary prevention cohort, the weighted rate difference was 9 per 1000 person-years (95% CI, 5-12 per 1000 person-years) and the adjusted sub-hazard ratio was 1.32 (95% CI, 1.18-1.48), corresponding to 1 excess MACE per 112 persons who discontinued statins per year. In the secondary prevention cohort, the weighted rate difference was 13 per 1000 person-years (95% CI, 8-17 per 1000 person-years) and the adjusted sub-hazard ratio was 1.28 (95% CI, 1.18-1.39), corresponding to 1 excess MACE per 77 persons who discontinued statins per year.
CONCLUSIONS AND RELEVANCE: In this cohort study, among older adults receiving long-term statin treatment, discontinuation of statins was associated with a higher rate of MACE compared with statin continuation in both the primary and the secondary prevention cohorts. These findings suggest a need for robust evidence from randomized clinical trials.
参考来源
- Thompson W, Morin L, Jarbøl DE, et al. Statin Discontinuation and Cardiovascular Events Among Older People in Denmark. JAMA Netw Open. 2021. PMID: 34854906. doi:10.1001/jamanetworkopen.2021.36802
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。